Cargando…

Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseases

Detalles Bibliográficos
Autor principal:	Pretsch, Dagmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374588/ https://www.ncbi.nlm.nih.gov/pubmed/33907011 http://dx.doi.org/10.4103/1673-5374.313039

Ejemplares similares

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models
por: Tomioka, Ikuo, et al.
Publicado: (2018)

Genetic targeting of astrocytes to combat neurodegenerative disease
por: Kéry, Rachel, et al.
Publicado: (2019)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
por: Hansen, Henrik H., et al.
Publicado: (2020)

Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective
por: Coppedè, Fabio
Publicado: (2022)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Combating the Sigatoka Disease Complex on Banana
por: Friesen, Timothy L.
Publicado: (2016)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
por: Fernandez, Caridad Ivette, et al.
Publicado: (2017)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Mediation of metal chelation in cysteine-derived tetramate systems
por: Zhang, Ruirui, et al.
Publicado: (2021)

Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans
por: Pretsch, Dagmar, et al.
Publicado: (2020)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

A global campaign to combat ageism
por: Officer, Alana, et al.
Publicado: (2018)

Crumbling the Castle: Targeting DNABII Proteins for Collapsing Bacterial Biofilms as a Therapeutic Approach to Treat Disease and Combat Antimicrobial Resistance
por: Rogers, James V., et al.
Publicado: (2022)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Can foods influence the onset and progress of neurodegenerative diseases?
por: Piemontese, Luca, et al.
Publicado: (2022)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

A substrate scaffold for assessment of nerve regeneration and neurodegenerative diseases
por: Chen, Wei-Hsin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b4erccdasm3tjr6l9ubek8r6t9